Vertex Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
06.02.24
/
50%
€383.95
Target price
06.02.25
€502.09
Performance (%)
17.98%
Price
24.07.24
€453.00
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan currently has a performance of 17.98%. This prediction currently runs until 06.02.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 1.444% | 1.444% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Wells Fargo & Company from $500.00 to $540.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€439.95
24.06.24
24.06.24
€516.65
24.06.25
24.06.25
2.97%
24.07.24
24.07.24